dsdsa

product

Factory wholesale Osimertinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Our corporation has been specializing in brand strategy. Customers' gratification is our greatest advertising. We also source OEM company for Dihexa, Treatment Of Hepatitis C, Bpc 157, Seeing believes! We sincerely welcome the new customers abroad to set up business relationships and also expect to consolidate the relationships with the long-established customers.
Factory wholesale Osimertinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai Detail:

Product name Docetaxel Trihydrate
Synonyms (αR,βS)-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,hydrate (1:3)
CAS No. 148408-66-6
Appearance White to off-white crystalline powder
Molecular Formula C43H53NO14.3(H2O)
Molecular Weight 861.94
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Docetaxel Trihydrate CAS# 148408-66-6

ITEMS

STANDARDS

RESULTS

Characters A:White to off-white crystalline powder Conforms
B:Solubility :Insoluble in water ,soluble in ethanol and acetone   Conforms
Specific Rotation             ﹣38.5°~﹣41.5° ﹣40°
Identification 1.IR:  The same to check sample    Conforms
2.UV:  λmax232nm    Conforms
  1. Colour reactions: positive reactions
   Conforms
  1. HPLC: retention times is same as the standard sample
   Conforms
Impurities Total impurities: NMT 1.0% 0.29%
Impurities A: NMT 0.5% 0.0551%
Impurities B: NMT 0.3% 0.0470%
Impurities C: NMT 0.3% 0.0535%
Any other single impurity: NMT 0.1% 0.0702%
Water 5.0% – 7.0% 6.15%
Residue on ignition NMT 0.1% w/w 0.03%
Heavy metal NMT 20ppm Conforms
Assay 97.5%~ 102.0% 99.7%
Conclusion

It meets EP7.5.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Factory wholesale Osimertinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

Factory wholesale Osimertinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

Factory wholesale Osimertinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures


Related Product Guide:

Our concentrate on should be to consolidate and enhance the quality and service of present products, meanwhile consistently produce new products to meet unique customers' demands for Factory wholesale Osimertinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai , The product will supply to all over the world, such as: Tunisia, Ethiopia, Brazil, To meet the requirements of individual customers for each bit more perfect service and stable quality products. We warmly welcome customers around the world to visit us, with our multi-faceted cooperation, and jointly develop new markets, create a brilliant future!
  • Staff is skilled, well-equipped, process is specification, products meet the requirements and delivery is guaranteed, a best partner!
    5 Stars By Amber from Sacramento - 2018.05.22 12:13
    The quality of the products is very good, especially in the details, can be seen that the company work actively to satisfy customer's interest, a nice supplier.
    5 Stars By Jacqueline from Guatemala - 2017.04.08 14:55
    Write your message here and send it to us